Minerva Neurosciences (NERV) Tops Q3 EPS by 12c

Minerva Neurosciences (NASDAQ: NERV) reported Q3 EPS of ($0.24), $0.12 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Conduent to sell tolling unit to Quarterhill for $70 million
• Air Products cancels Louisiana clean energy project, faces $2.9B charge